{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:44:23Z","timestamp":1792183463035,"version":"4.4.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11064-025-04438-3","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T17:39:59Z","timestamp":1750873199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Possible Mitigating Effect of Nobiletin on Rotenone\u2013Induced Parkinsonism in Male Albino Rat Model: Targeting Bmal1\/Nrf2 Mediated Ferroptosis and Restoring Mitochondrial Mitophagy"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4522-9899","authenticated-orcid":false,"given":"Sarah Ragab","family":"Abd El-Khalik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norhan Ahmed","family":"AbuoHashish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Nasif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba M.","family":"Arakeep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"El-Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa Mohammed","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada Hashem","family":"Ayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"issue":"10","key":"4438_CR1","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1097\/MS9.0000000000001142","volume":"85","author":"P Prajjwal","year":"2023","unstructured":"Prajjwal P, Sanga HSF, Acharya K, Tango T, John J, Rodriguez RS, Marsool MDM, Sulaimanov M, Ahmed A, Hussin OA (2023) Parkinson\u2019s disease updates: Addressing the pathophysiology, risk factors, genetics, diagnosis, along with the medical and surgical treatment. Annal Med Surg 85(10):4887\u20134902","journal-title":"Annal Med Surg"},{"key":"4438_CR2","doi-asserted-by":"publisher","first-page":"105799","DOI":"10.1016\/j.parkreldis.2023.105799","volume":"115","author":"CK Bhusal","year":"2023","unstructured":"Bhusal CK, Uti DE, Mukherjee D, Alqahtani T, Alqahtani S, Bhattacharya A, Akash S (2023) Unveiling Nature\u2019s potential: promising natural compounds in Parkinson\u2019s disease management. Parkinsonism Related Disorders 115:105799","journal-title":"Parkinsonism Related Disorders"},{"issue":"1","key":"4438_CR3","doi-asserted-by":"publisher","first-page":"049082","DOI":"10.1242\/dmm.049082","volume":"15","author":"R Landau","year":"2022","unstructured":"Landau R, Halperin R, Sullivan P, Zibly Z, Leibowitz A, Goldstein DS, Sharabi Y (2022) The rat rotenone model reproduces the abnormal pattern of central catecholamine metabolism found in Parkinson\u2019s disease. Dis Model Mech 15(1):049082","journal-title":"Dis Model Mech"},{"key":"4438_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-021-00504-w","volume":"17","author":"J Hunt","year":"2022","unstructured":"Hunt J, Coulson EJ, Rajnarayanan R, Oster H, Videnovic A, Rawashdeh O (2022) Sleep and circadian rhythms in Parkinson\u2019s disease and preclinical models. Mol Neurodegener 17:1\u201321","journal-title":"Mol Neurodegener"},{"issue":"10","key":"4438_CR5","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3390\/biology12101294","volume":"12","author":"P Rathor","year":"2023","unstructured":"Rathor P, Ch R (2023) Metabolic basis of circadian dysfunction in Parkinson\u2019s disease. Biology 12(10):1294","journal-title":"Biology"},{"issue":"1","key":"4438_CR6","doi-asserted-by":"publisher","first-page":"4854732","DOI":"10.1155\/2018\/4854732","volume":"2018","author":"Y Wang","year":"2018","unstructured":"Wang Y, Lv D, Liu W, Li S, Chen J, Shen Y, Wang F, Hu LF, Liu CF (2018) Disruption of the circadian clock alters antioxidative defense via the SIRT1-BMAL1 pathway in 6-OHDA-induced models of Parkinson\u2019s disease. Oxidat Med Cellular Longevity 2018(1):4854732","journal-title":"Oxidat Med Cellular Longevity"},{"key":"4438_CR7","volume-title":"Circadian protein BMAL1 regulates astrocyte activation and protein degradation in health and disease","author":"CA McKee","year":"2023","unstructured":"McKee CA (2023) Circadian protein BMAL1 regulates astrocyte activation and protein degradation in health and disease. Washington University in St. Louis"},{"issue":"7","key":"4438_CR8","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","volume":"28","author":"D Moujalled","year":"2021","unstructured":"Moujalled D, Strasser A, Liddell JR (2021) Molecular mechanisms of cell death in neurological diseases. Cell Death Differ 28(7):2029\u20132044","journal-title":"Cell Death Differ"},{"key":"4438_CR9","doi-asserted-by":"publisher","first-page":"102077","DOI":"10.1016\/j.arr.2023.102077","volume":"91","author":"XS Ding","year":"2023","unstructured":"Ding XS, Gao L, Han Z, Eleuteri S, Shi W, Shen Y, Song ZY, Su M, Yang Q, Qu Y, Simon DK (2023) Ferroptosis in Parkinson\u2019s disease: molecular mechanisms and therapeutic potential. Ageing Res Rev 91:102077","journal-title":"Ageing Res Rev"},{"key":"4438_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41416-019-0660-x","volume":"122","author":"N Liu","year":"2020","unstructured":"Liu N, Lin X, Huang C (2020) Activation of the reverse trans-sulfuration pathway through NRF2\/CBS confers erastin-induced ferroptosis resistance. Br J Cancer 122:279\u2013292","journal-title":"Br J Cancer"},{"issue":"10","key":"4438_CR11","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1073\/pnas.0400282101","volume":"101","author":"JH Suh","year":"2004","unstructured":"Suh JH, Shenvi SV, Dixon BM, Liu H, Jaiswal AK, Liu RM, Hagen TM (2004) Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci U S A 101(10):3381\u20133386","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4438_CR12","doi-asserted-by":"publisher","first-page":"44373","DOI":"10.1038\/srep44373","volume":"7","author":"B Koentjoro","year":"2017","unstructured":"Koentjoro B, Park JS, Sue CM (2017) Nix restores mitophagy and mitochondrial function to protect against PINK1\/Parkin-related Parkinson\u2019s disease. Sci Rep 7(1):44373","journal-title":"Sci Rep"},{"issue":"12","key":"4438_CR13","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1093\/brain\/awac405","volume":"145","author":"IG Ganley","year":"2022","unstructured":"Ganley IG (2022) Strengthening the link between mitophagy and Parkinson\u2019s disease. Brain 145(12):4154\u20134156","journal-title":"Brain"},{"key":"4438_CR14","doi-asserted-by":"publisher","first-page":"1354809","DOI":"10.3389\/fphar.2024.1354809","volume":"15","author":"Y Cheng","year":"2024","unstructured":"Cheng Y, Feng S, Sheng C, Yang C, Li Y (2024) NOB from citrus peel: a promising therapeutic agent for liver disease-pharmacological characteristics, mechanisms, and potential applications. Front Pharmacol 15:1354809","journal-title":"Front Pharmacol"},{"key":"4438_CR15","doi-asserted-by":"publisher","DOI":"10.31665\/JFB.2023.18361","author":"H Fang","year":"2023","unstructured":"Fang H, Zhang L, Zhao H (2023) Potential role of NOB in Alzheimer\u2019s disease. J Food Bioact. https:\/\/doi.org\/10.31665\/JFB.2023.18361","journal-title":"J Food Bioact"},{"key":"4438_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neuroscience.2013.11.051","volume":"259","author":"Y Yabuki","year":"2014","unstructured":"Yabuki Y, Ohizumi Y, Yokosuka A, Mimaki Y, Fukunaga K (2014) Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice. Neuroscience 259:126\u2013141","journal-title":"Neuroscience"},{"key":"4438_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-03920-7","author":"EA Salem","year":"2025","unstructured":"Salem EA, Alqahtani SM, El-Shoura EA, Zaghlool SS, Abdelzaher LA, Mohamed SA, Alalhareth IS, Sheref AA (2025) Neuroprotective effects of semaglutide and metformin against rotenone-induced neurobehavioral changes in male diabetic rats. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-03920-7","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"4438_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.pharep.2018.08.004","volume":"71","author":"SA Zaitone","year":"2019","unstructured":"Zaitone SA, Ahmed E, Elsherbiny NM, Mehanna ET, El-Kherbetawy MK, ElSayed MH et al (2019) Caffeic acid improves locomotor activity and lessens inflammatory burden in a rat model of rotenone-induced nigral neurodegeneration: relevance to Parkinson\u2019s disease therapy. Pharmacol Rep 71:32\u201341. https:\/\/doi.org\/10.1016\/j.pharep.2018.08.004","journal-title":"Pharmacol Rep"},{"issue":"4","key":"4438_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11011-025-01602-0","volume":"40","author":"M Belviranl\u0131","year":"2025","unstructured":"Belviranl\u0131 M, Okudan N, Sezer T (2025) Potential therapeutic effects of curcumin, with or without L-DOPA, on motor and cognitive functions and hippocampal changes in rotenone-treated rats. Metab Brain Dis 40(4):174","journal-title":"Metab Brain Dis"},{"issue":"3","key":"4438_CR20","doi-asserted-by":"publisher","first-page":"645","DOI":"10.5114\/AOMS.2016.59508","volume":"14","author":"EO Ahiskalioglu","year":"2018","unstructured":"Ahiskalioglu EO, Aydin P, Ahiskalioglu A, Suleyman B, Kuyrukluyildiz U, Kurt N, Altuner D, Coskun R (2018) The effects of ketamine and thiopental used alone or in combination on the brain, heart, and bronchial tissues of rats. Arch Med Sci 14(3):645. https:\/\/doi.org\/10.5114\/AOMS.2016.59508","journal-title":"Arch Med Sci"},{"key":"4438_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"D Lowry","year":"1951","unstructured":"Lowry D (1951) Protein measurements with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"4438_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney DK, Andreas V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88\u201395","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"4438_CR23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25(4):402\u2013408","journal-title":"Methods"},{"key":"4438_CR24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351\u2013358","journal-title":"Anal Biochem"},{"key":"4438_CR25","first-page":"158","volume":"70","author":"DE Paglia","year":"1967","unstructured":"Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158\u2013169","journal-title":"J Lab Clin Med"},{"key":"4438_CR26","first-page":"882","volume":"61","author":"E Beutler","year":"1963","unstructured":"Beutler E, Duron O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61:882\u2013888","journal-title":"J Lab Clin Med"},{"issue":"2","key":"4438_CR27","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1073\/pnas.61.2.748","volume":"61","author":"R Tenhunen","year":"1968","unstructured":"Tenhunen R, Marver HS, Schmid R (1968) The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci 61(2):748\u2013755","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"4438_CR28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1186\/s12877-022-03296-w","volume":"22","author":"D Baik","year":"2022","unstructured":"Baik D et al (2022) Prevalence and patterns of the concurrent use of anticholinergics for the motor symptoms of Parkinson\u2019s disease and acetylcholinesterase inhibitors in Parkinson\u2019s disease patients with dementia: a cross-sectional study using Korea National Health Insurance claims data. BMC Geriatr 22(1):609","journal-title":"BMC Geriatr"},{"issue":"17","key":"4438_CR29","doi-asserted-by":"publisher","first-page":"9290","DOI":"10.3390\/ijms22179290","volume":"22","author":"\u0141J Walczak-Nowicka","year":"2021","unstructured":"Walczak-Nowicka \u0141J, Herbet M (2021) Acetylcholinesterase inhibitors in the treatment of neurodegenerative diseases and the role of acetylcholinesterase in their pathogenesis. Int J Mol Sci 22(17):9290","journal-title":"Int J Mol Sci"},{"key":"4438_CR30","doi-asserted-by":"publisher","first-page":"111344","DOI":"10.1016\/j.ecoenv.2020.111344","volume":"205","author":"NA El-Sherbeeny","year":"2020","unstructured":"El-Sherbeeny NA et al (2020) The protective effect of biochanin A against rotenone-induced neurotoxicity in mice involves enhancing of PI3K\/Akt\/mTOR signaling and beclin-1 production. Ecotoxicol Environ Saf 205:111344","journal-title":"Ecotoxicol Environ Saf"},{"issue":"21","key":"4438_CR31","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.3390\/molecules27217159","volume":"27","author":"A Altharawi","year":"2022","unstructured":"Altharawi A et al (2022) Europinidin Inhibits rotenone-activated parkinson\u2019s disease in rodents by decreasing lipid peroxidation and inflammatory cytokines pathways. Molecules 27(21):7159","journal-title":"Molecules"},{"issue":"5","key":"4438_CR32","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1089\/jmf.2017.4078","volume":"21","author":"UJ Jung","year":"2018","unstructured":"Jung UJ, Kim SR (2018) Beneficial effects of flavonoids against Parkinson\u2019s disease. J Med Food 21(5):421\u2013432","journal-title":"J Med Food"},{"issue":"1","key":"4438_CR33","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/s40001-023-01450-7","volume":"28","author":"Y Pang","year":"2023","unstructured":"Pang Y et al (2023) A review on recent advances on NOB in central and peripheral nervous system diseases. Eur J Med Res 28(1):485","journal-title":"Eur J Med Res"},{"key":"4438_CR34","doi-asserted-by":"publisher","first-page":"113718","DOI":"10.1016\/j.biopha.2022.113718","volume":"155","author":"M Pang","year":"2022","unstructured":"Pang M et al (2022) Molecular understanding of the translational models and the therapeutic potential natural products of Parkinson\u2019s disease. Biomed Pharmacother 155:113718","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4438_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12906-019-2738-7","volume":"20","author":"T Wang","year":"2020","unstructured":"Wang T et al (2020) Neuroprotective effects of Danshensu on rotenone-induced Parkinson\u2019s disease models in vitro and in vivo. BMC Complement Med Therapies 20(1):20","journal-title":"BMC Complement Med Therapies"},{"issue":"6","key":"4438_CR36","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1021\/acschemneuro.2c00308","volume":"14","author":"Y Cheng","year":"2023","unstructured":"Cheng Y et al (2023) Mitochondrial inhibitor rotenone triggers and enhances neuronal ferroptosis following intracerebral hemorrhage. ACS Chem Neurosci 14(6):1071\u20131079","journal-title":"ACS Chem Neurosci"},{"issue":"7","key":"4438_CR37","doi-asserted-by":"publisher","first-page":"101284","DOI":"10.1016\/j.isci.2020.101284","volume":"23","author":"T Liang","year":"2020","unstructured":"Liang T et al (2020) Brain hepcidin suppresses major pathologies in experimental parkinsonism. iSscience 23(7):101284","journal-title":"iSscience"},{"key":"4438_CR38","doi-asserted-by":"publisher","first-page":"919233","DOI":"10.3389\/fphar.2022.919233","volume":"13","author":"XX Yang","year":"2022","unstructured":"Yang XX, Yang R, Zhang F (2022) Role of Nrf2 in Parkinson\u2019s disease: toward new perspectives. Front Pharmacol 13:919233","journal-title":"Front Pharmacol"},{"key":"4438_CR39","doi-asserted-by":"publisher","first-page":"2360872","DOI":"10.1155\/2020\/2360872","volume":"2020","author":"S Perc\u00e1rio","year":"2020","unstructured":"Perc\u00e1rio S et al (2020) Oxidative stress in Parkinson\u2019s Disease: potential benefits of antioxidant supplementation. Oxid Med Cell Longev 2020:2360872","journal-title":"Oxid Med Cell Longev"},{"key":"4438_CR40","doi-asserted-by":"publisher","first-page":"100377","DOI":"10.1016\/j.prmcm.2024.100377","volume":"10","author":"L Liu","year":"2024","unstructured":"Liu L et al (2024) Natural flavonoids act as potent ferroptosis inhibitors and their potentials in the treatment of ferroptosis-associated diseases. Pharmacol Res Modern Chin Med 10:100377","journal-title":"Pharmacol Res Modern Chin Med"},{"issue":"1","key":"4438_CR41","doi-asserted-by":"publisher","first-page":"100171","DOI":"10.1016\/j.jnrt.2024.100171","volume":"13","author":"X Liu","year":"2025","unstructured":"Liu X et al (2025) HIF1\u03b1\/SLC7A11 signaling attenuates 6-hydroxydopamine-induced ferroptosis in animal and cell models of Parkinson\u2019s disease. J Neurorestoratol 13(1):100171","journal-title":"J Neurorestoratol"},{"key":"4438_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116112","volume":"171","author":"X Xu","year":"2024","unstructured":"Xu X et al (2024) The mechanisms of ferroptosis and its role in atherosclerosis. Biomed Pharmacother 171:116112","journal-title":"Biomed Pharmacother"},{"key":"4438_CR43","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/biomedicines10030595","volume":"10","author":"YH Lo","year":"2022","unstructured":"Lo YH et al (2022) NOB alleviates ferroptosis-associated renal injury, inflammation, and fibrosis in a unilateral ureteral obstruction mouse model. Biomedicines 10:595","journal-title":"Biomedicines"},{"key":"4438_CR44","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.3390\/ijms20143380","volume":"20","author":"A Nakajima","year":"2019","unstructured":"Nakajima A, Ohizumi Y (2019) Potential benefits of NOB, A citrus flavonoid, against Alzheimer\u2019s disease and Parkinson\u2019s disease. Int J Mol Sci 20:3380","journal-title":"Int J Mol Sci"},{"key":"4438_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116512","volume":"174","author":"W Zhang","year":"2024","unstructured":"Zhang W et al (2024) GPX4, ferroptosis, and diseases. Biomed Pharmacother 174:116512","journal-title":"Biomed Pharmacother"},{"key":"4438_CR46","doi-asserted-by":"publisher","first-page":"101817","DOI":"10.1016\/j.arr.2022.101817","volume":"84","author":"J Li","year":"2023","unstructured":"Li J et al (2023) PINK1\/Parkin-mediated mitophagy in neurodegenerative diseases. Ageing Res Rev 84:101817","journal-title":"Ageing Res Rev"},{"key":"4438_CR47","doi-asserted-by":"publisher","first-page":"111207","DOI":"10.1016\/j.intimp.2023.111207","volume":"125","author":"HY Khidr","year":"2023","unstructured":"Khidr HY et al (2023) Formoterol attenuated mitochondrial dysfunction in rotenone-induced Parkinson\u2019s disease in a rat model: role of PINK-1\/PARKIN and PI3K\/Akt\/CREB\/BDNF\/TrKB axis. Int Immunopharmacol 125:111207","journal-title":"Int Immunopharmacol"},{"key":"4438_CR48","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/jnc.13412","volume":"136","author":"D Ivankovic","year":"2016","unstructured":"Ivankovic D, Chau K-Y, Schapira AHV, Gegg ME (2016) Mitochondrial and lysosomal biogenesis are activated following PINK1\/parkin-mediated mitophagy. J Neurochem 136:388\u2013402. https:\/\/doi.org\/10.1111\/jnc.13412","journal-title":"J Neurochem"},{"key":"4438_CR49","doi-asserted-by":"publisher","DOI":"10.20517\/jca.2023.46","author":"Y Shiheido-Watanabe","year":"2024","unstructured":"Shiheido-Watanabe Y, Sadoshima J (2024) NOB, a polymethoxylated flavonoid, regulates cell survival via the nuclear receptor ROR\u03b1 in cardiomyocytes. J Cardiovasc Aging. https:\/\/doi.org\/10.20517\/jca.2023.46","journal-title":"J Cardiovasc Aging"},{"issue":"1","key":"4438_CR50","doi-asserted-by":"publisher","first-page":"7889","DOI":"10.1038\/s41598-024-55614-4","volume":"14","author":"W Song","year":"2024","unstructured":"Song W et al (2024) NOB alleviates cisplatin-induced ototoxicity via activating autophagy and inhibiting NRF2\/GPX4-mediated ferroptosis. Sci Rep 14(1):7889","journal-title":"Sci Rep"},{"key":"4438_CR51","doi-asserted-by":"publisher","first-page":"111163","DOI":"10.1016\/j.fct.2020.111163","volume":"137","author":"SY Park","year":"2020","unstructured":"Park SY, Koh HC (2020) FUNDC1 regulates receptor-mediated mitophagy independently of the PINK1\/Parkin-dependent pathway in rotenone-treated SH-SY5Y cells. Food Chem Toxicol 137:111163","journal-title":"Food Chem Toxicol"},{"key":"4438_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911394","author":"A Morales-Mart\u00ednez","year":"2022","unstructured":"Morales-Mart\u00ednez A et al (2022) Oxidative stress and mitochondrial complex I dysfunction correlate with neurodegeneration in an \u03b1-synucleinopathy animal model. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms231911394","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4438_CR53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13024-020-00367-7","volume":"15","author":"P Ge","year":"2020","unstructured":"Ge P, Dawson VL, Dawson TM (2020) PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson\u2019s disease. Mol Neurodegener 15(1):20","journal-title":"Mol Neurodegener"},{"issue":"8","key":"4438_CR54","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.jmb.2020.01.037","volume":"432","author":"X Hou","year":"2020","unstructured":"Hou X et al (2020) Autophagy in Parkinson\u2019s Disease. J Mol Biol 432(8):2651\u20132672","journal-title":"J Mol Biol"},{"key":"4438_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.967813","author":"A Magdy","year":"2022","unstructured":"Magdy A et al (2022) Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson\u2019s disease rat model. Front Cellular Neurosci. https:\/\/doi.org\/10.3389\/fncel.2022.967813","journal-title":"Front Cellular Neurosci"},{"key":"4438_CR56","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.2c00706","author":"AS Rathore","year":"2023","unstructured":"Rathore AS et al (2023) Curcumin modulates p62-Keap1-Nrf2-mediated autophagy in rotenone-induced Parkinson\u2019s disease mouse models. ACS Chem Neurosci. https:\/\/doi.org\/10.1021\/acschemneuro.2c00706","journal-title":"ACS Chem Neurosci"},{"key":"4438_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.12","author":"B Ning","year":"2023","unstructured":"Ning B et al (2023) An update on the bridging factors connecting autophagy and Nrf2 antioxidant pathway. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2023.12","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"4438_CR58","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.1007\/s12035-020-02071-5","volume":"57","author":"H Wang","year":"2020","unstructured":"Wang H et al (2020) NOB ameliorates NLRP3 inflammasome-mediated inflammation through promoting autophagy via the AMPK pathway. Mol Neurobiol 57(12):5056\u20135068","journal-title":"Mol Neurobiol"},{"key":"4438_CR59","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1474-4422(18)30461-7","volume":"18","author":"Y Leng","year":"2019","unstructured":"Leng Y, Musiek ES, Hu K, Cappuccio FP, Yaffe K (2019) Association between circadian rhythms and neurodegenerative diseases. Lancet Neurol 18:307\u2013318","journal-title":"Lancet Neurol"},{"issue":"10","key":"4438_CR60","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13704","volume":"21","author":"R Fan","year":"2022","unstructured":"Fan R et al (2022) Importance of Bmal1 in Alzheimer\u2019s disease and associated aging-related diseases: mechanisms and interventions. Aging Cell 21(10):e13704","journal-title":"Aging Cell"},{"issue":"7","key":"4438_CR61","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/biom11071004","volume":"11","author":"E Kim","year":"2021","unstructured":"Kim E et al (2021) Effects of the clock modulator NOB on Circadian Rhythms and pathophysiology in female mice of an Alzheimer\u2019s disease model. Biomolecules 11(7):1004","journal-title":"Biomolecules"},{"issue":"10","key":"4438_CR62","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3390\/nu16101491","volume":"16","author":"C Ryan","year":"2024","unstructured":"Ryan C et al (2024) NOB stimulates adrenal hormones and modulates the circadian clock in mice. Nutrients 16(10):1491","journal-title":"Nutrients"},{"key":"4438_CR63","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2147\/JIR.S345895","volume":"15","author":"Y Zhong","year":"2022","unstructured":"Zhong Y et al (2022) Nrf2 inhibits the progression of parkinson\u2019s disease by upregulating AABR07032261.5 to repress pyroptosis. J Inflamm Res 15:669\u2013685","journal-title":"J Inflamm Res"},{"issue":"1","key":"4438_CR64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5607\/en20051","volume":"30","author":"K Amarsanaa","year":"2021","unstructured":"Amarsanaa K et al (2021) Nobiletin exhibits neuroprotective effects against mitochondrial complex i inhibition via regulating apoptotic signaling. Exp Neurobiol 30(1):73\u201386","journal-title":"Exp Neurobiol"},{"key":"4438_CR65","doi-asserted-by":"publisher","first-page":"719631","DOI":"10.3389\/fphar.2021.719631","volume":"12","author":"S Bevinakoppamath","year":"2022","unstructured":"Bevinakoppamath S, Ramachandra SC, Yadav AK, Basavaraj V, Vishwanath P, Prashant A (2022) Understanding the emerging link between circadian rhythm, Nrf2 pathway, and breast cancer to overcome drug resistance. Front Pharmacol 12:719631","journal-title":"Front Pharmacol"},{"key":"4438_CR66","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fnins.2020.00267","volume":"14","author":"X Song","year":"2020","unstructured":"Song X, Long D (2020) Nrf2 and ferroptosis: a new research direction for neurodegenerative diseases. Front Neurosci 14:267","journal-title":"Front Neurosci"},{"issue":"46","key":"4438_CR67","doi-asserted-by":"publisher","first-page":"80612","DOI":"10.18632\/oncotarget.20811","volume":"8","author":"L Qiao","year":"2017","unstructured":"Qiao L et al (2017) The clock gene, brain and muscle Arnt-like 1, regulates autophagy in high glucose-induced cardiomyocyte injury. Oncotarget 8(46):80612\u201380624","journal-title":"Oncotarget"},{"key":"4438_CR68","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbrc.2023.04.035","volume":"661","author":"C Yang","year":"2023","unstructured":"Yang C, Deng Z, Zeng Q, Chang X, Wu X, Li G (2023) BMAL1 involved in autophagy and injury of thoracic aortic endothelial cells of rats induced by intermittent heat stress through the AMPK\/mTOR\/ULK1 pathway. Biochem Biophys Res Commun 661:34\u201341","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"4438_CR69","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/med.21714","volume":"41","author":"C Bento-Pereira","year":"2021","unstructured":"Bento-Pereira C, Dinkova-Kostova AT (2021) Activation of transcription factor Nrf2 to counteract mitochondrial dysfunction in Parkinson\u2019s disease. Med Res Rev 41(2):785\u2013802","journal-title":"Med Res Rev"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04438-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-025-04438-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04438-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T22:51:23Z","timestamp":1757199083000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-025-04438-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["4438"],"URL":"https:\/\/doi.org\/10.1007\/s11064-025-04438-3","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}],"article-number":"208"}}